Evidence map›Paper›PMID 42211832›Full record

ArticleFrontiers in neuroinformatics2026

Reliability and diagnostic performance of an automated MRI-based classifier compared with radiologists in Alzheimer's disease.

Nurmakhan Zholshybek, Elnora Abdurakhmanova, Almas Bimakhan, Dinara Jumadilova, Zhanibek Baiturlin, Joseph Almazan, Srinivasa Rao Bolla

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in neuroinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Nurmakhan ZholshybekDepartment of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.
Elnora AbdurakhmanovaDepartment of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana, Kazakhstan.
Almas BimakhanDepartment of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana, Kazakhstan.
Dinara JumadilovaDepartment of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.
Zhanibek BaiturlinDepartment of Radiology and Radiosurgery, National Center for Neurosurgery, Astana, Kazakhstan.
Joseph AlmazanDepartment of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.
Srinivasa Rao BollaDepartment of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana, Kazakhstan.

Funding

Project 1U19AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MONICA G. RIVERA-MINDT · 2016 to 2026
$226.7M
NIA NIH HHS U19 AG024904
6 · The paper itself

Abstract

Reliable imaging biomarkers are essential for improving early detection of Alzheimer's disease (AD). We evaluated whether an automated MRI-based classifier provides diagnostic performance comparable to expert radiologists in differentiating cognitively normal (CN) individuals from patients with AD using standardized ADNI data. Thirty-eight structural MRI datasets (20 CN, 18 AD) were analyzed. An automated multi-class volumetric classifier and two board-certified radiologists independently assigned probability scores across seven diagnostic categories. Performance was evaluated using a partial-credit scoring rule to account for probabilistic ties. Diagnostic performance for CN-AD discrimination was assessed using accuracy, sensitivity, specificity, receiver operating characteristic (ROC) analysis, inter-observer agreement metrics, Brier scores for calibration, and decision curve analysis (DCA) for clinical utility. The automated classifier achieved an accuracy of 0.66, sensitivity of 0.56, and specificity of 0.75. Radiologists demonstrated comparable performance with inherent inter-observer variability. Agreement between automated and human assessments was fair at the categorical level, with low concordance for continuous probability estimates. ROC analysis based on continuous AD probabilities demonstrated high discrimination performance for the automated model (AUC = 0.90), exceeding that of radiologists (AUC = 0.71 and 0.62). DCA indicated that the automated pipeline provides a positive net benefit as a second-opinion tool. This exploratory study emphasizes the impact of evaluation frameworks on performance metrics and supports further validation using multi-modal data in larger cohorts.

Indexed as

Alzheimer’s diseaseartificial intelligencebrain MRIcognitive disordersdiagnostic accuracy

Identifiers

PMID42211832
PMCPMC13213848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.